Skip to content
  • KOSPI 2680.57 +24.24 +0.91%
  • KOSDAQ 865.57 +8.75 +1.02%
  • KOSPI200 363.81 +2.79 +0.77%
  • USD/KRW 1374.7 -4.3 -0.31%
  • JPY100/KRW 884.48 +13.16 +1.51%
  • EUR/KRW 1475.19 +0.63 +0.04%
  • CNH/KRW 189.51 -0.19 -0.1%
View Market Snapshot
Artificial intelligence

Lunit to export breast cancer detecting solutions to Hong Kong, Mongolia

The S.Korea's medical imaging startup hopes to expand sales of AI breast cancer diagnosis solutions in East Asian countries

By Dec 22, 2022 (Gmt+09:00)

1 Min read

Lunit Insight MMG
Lunit Insight MMG

South Korea's AI-based medical imaging equipment firm Lunit will export AI breast cancer diagnosis solutions to large hospitals in Hong Kong and Mongolia.

Lunit announced on Thursday that it has signed a contract to supply Lunit Insight MMG, an AI breast cancer screening solution, to Hong Kong Women's Imaging (HKWI), Hong Kong's largest diagnosis imaging center, and Mongolia's National Cancer Center.

Starting with this contract, the company expects to supply solutions to hospitals under the Hong Kong Hospital Authority, a Hong Kong public hospital management organization, and other hospitals in Mongolia.

"I hope this deal will serve as a bridgehead for entering East Asian countries such as China and Singapore," said Suh Beom-seok, CEO of Lunit.

Write to Jung-Eun Kim at likesmile@hankyung.com
More to Read
Comment 0
0/300